Potential treatment strategy for the rare osimertinib resistant EGFR L718Q mutation

J Thorac Dis. 2022 Mar;14(3):599-601. doi: 10.21037/jtd-22-100.
No abstract available

Publication types

  • Editorial
  • Comment